Experts say "100 percent bioavailability".
Greenbird developed THE revolution in the health and nutritional supplement market. Very few people know: Dietary supplements are by no means fully effective in our body.
Because a large part of the important active ingredients is not used by our body at all, but is excreted again. This applies to every dietary supplement. And for every body. Its over NOW!
Food supplements that are 99% used by the body.
What does that mean?
Dietary supplements that actually develop their full effect! And thats 100% natural!
Our goal was clear:
We want to achieve almost one hundred percent bioavailability of fat-soluble active ingredients with our products.
Fat-soluble substances and vitamins are made water-soluble and can thus be absorbed by the body much better. The active ingredients are absorbed by the cells in tens of times higher quantities.
How it works?
With the bodys own micelles, which are present and continuously formed in the body. One of their tasks is to digest fat. And this is very energy-consuming. With the globally unique and patented process in our products - the so-called micelle formation - this step is taken from the body.
Exclusive distribution for D-A-CH area.
The Switzerland-based Greenbird Medical AG researches and develops in the field of the absorption of nutrients, vitamins and dietary supplements.
After years of development, the company is revolutionizing this absorption of active ingredients with its products. Already today exclusively on the entire German, Austrian and Swiss market - as well as in numerous other countries in Europe in the future.
For more than 30 years, various methods have been tested to artificially manufacture micelles.
Cleaning waters with micelles have been an absolute game changer in the cosmetics market for several years.
Breakthrough in the health and nutritional supplement sector through Greenbirds Swiss partner.
Multi-patented and globally unique micellation process is honored with an international Pharma Award.
Construction of 38,000 m2 of laboratory and production space in Croatia.
Greenbird Medical receives exclusive sales licenses for Germany, Austria and Croatia.
Development of series production of a water-soluble product line and development of logistics for market entry.
Numerous active ingredients are in the test phase.
Greenbird Medical receives further exclusive sales licenses around the world, including in France, Belgium, Slovenia, Croatia, Serbia, Bosnia-Hercegovina, Montenegro, Hungary, Turkey, Albania, Qatar, Liechtenstein.
Market entry with the first product line.
Expansion into other EU countries.
Investments of several million euros in additional laboratory and manufacturing facilities.
Highest effectiveness and easy dosage.
The Greenbird products are simply dissolved in water, juice, tea or any other beverage using the small and handy bottle. Due to the highest bioavailability on the market, only a few drops are enough.
The current product line consists of the vitamins D3, K2, B12 and the coenzyme Q10 from Swiss organic cultivation. Further active ingredients are in the test phase.
Market entry in pharmacies in Germany, Austria and Switzerland is planned for March 2020.
Sales of dietary supplements - from pharmacies in Germany alone - have increased by an average of six percent per year in recent years and already reached a value of 2.1 billion euros in 2018.
Healthy, effective vitamins and minerals are right at the top of the list of dietary supplements in todays health-conscious times. No wonder, because thousands of studies have now proven the positive effects of various vital substances. And everyone wants to benefit from it.
So a lot of money is spent on vitality, beauty and health - a lot of money for almost no effect.
When fat-soluble active ingredients are taken orally, the human body must produce its own micelles, which cover this lipophilic active ingredient with a water-soluble shell in order to be able to absorb at least a fraction of it.
However, this process takes some time, and the vast majority of the active ingredients are excreted unused. This makes exact dosing almost impossible. This means that only a fraction of the active ingredients in conventional food supplements can actually be absorbed.
The multi-patented micellation process used in the manufacture of our products has been recognized by the World CPhI Excellence Formulation Pharma Award. This award is considered to be the highest possible confirmation of innovation in the pharmaceutical industry worldwide.
The process is a unique, natural method of making fat-soluble substances and vitamins water-soluble. This allows the body to absorb a significantly higher amount of the active ingredients into the cells.
These are nano-sized molecular structures. In other words, microscopic spheres that can transport active ingredients. And to where they are needed.
There are already contracts with sales partners across Europe, including in the following industries or point of sales:
This innovation opens up an exclusive and unprecedented potential in both the food and pharmaceutical industries.
For more than 30 years, various methods have been tested to artificially manufacture micelles. Now our Swiss partner has made this breakthrough!
Think of a very expensive drug: more than three quarters of the active ingredients are lost again because the body cannot absorb them. Its over now! And this also makes it clear why this patented process is already of great interest to pharmaceutical companies.
Is it for you too?
INFORM YOURSELF NOW
Be part of this innovation!
Project conception and market analysis
Securing exclusive sales and production licenses
Joint venture with Swiss cannabis producers
Development of an organizational structure and business model
Establishment of branches in Germany, Switzerland, Liechtenstein and Croatia
Formation of project teams
Contracts with sales partners
Planning a marketing and advertising campaign
Acquisition of 38,000 m2 of production space in Croatia, building permit for the construction of a new laboratory
Cooperation with logistics companies
Production 1st batch (raw material value EUR 2.5 million, 9 different products, number of items 200,000)
Sales start in mid / end of February 2020
TV campaign in Austria and Croatia
Research and development on other vital substances and nutrients, functional drinks and a product line for pet shops and pet pharmacies
Acquisition of 270,000 m2 of agricultural land in Croatia (organic cannabis cultivation). The European Commission has declared the project to be eligible for funding.
Greenbird Medical AG has cannabis cultivation, production, import-export and trade permits in the following countries: Germany, Liechtenstein and Croatia. More to come.
Expansion into other countries